Showing results 1 to 9 of 9
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
380MO A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure Proceeding/Conference:Annals of Oncology | 2020 | 7 | ||
5-Year Results of the Prognostic Roles of Serial Post-Intensity-Modulated Radiation Therapy Undetectable Plasma EBV DNA for Non-Metastatic Nasopharyngeal Carcinoma Proceeding/Conference:International Journal of Radiation Oncology - Biology - Physics | 2018 | 140 | ||
| 2021 | ||||
| 2021 | 5 | |||
| 2019 | 50 | |||
Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC) Journal:Scientific Reports | 2020 | 1 | ||
Palliative Liver Radiotherapy (RT) of Advanced Hepatocellular Carcinoma (HCC) in Endemic Population Proceeding/Conference:Radiotherapy & Oncology | 2019 | 26 | ||
| 2013 | 75 | |||
Plasma Levels of High Sensitivity Cardiac Troponin T in Adults with Repaired Tetralogy of Fallot Journal:Scientific Reports | 2015 | 60 |